Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.

Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.
复制标题

DOI:
10.1016/j.ymgme.2013.10.019
复制
发表时间:
2014-01
影响因子:
3.8
通讯作者:
Raymond, Gerald V.
Raymond, Gerald V.
中科院分区:
生物学2区
文献类型:
--
作者:
Theda, Christiane;Gibbons, Katy;DeFor, Todd E.;Donohue, Pamela K.;Golden, W. Christopher;Kline, Antonie D.;Gulamali-Majid, Fizza;Panny, Susan R.;Hubbard, Walter C.;Jones, Richard O.;Liu, Anita K.;Moser, Ann B.;Raymond, Gerald V.

文献摘要

参考文献

被引文献

相似文献

X连锁肾上腺脑白质营养不良(ALD)的特征是肾上腺功能不全和神经系统受累,发病年龄不一。血浆极长链脂肪酸在ALD中升高;即使在无症状患者中也是如此。我们以前证明,液相色谱串联质谱测量C26:0溶血磷脂酰胆碱可靠地识别受影响的男性。我们前瞻性地将该方法应用于4689例新生儿血斑样本,未观察到假阳性。我们表明,高通量新生儿ALD筛查是方法上可行的。
X-linked adrenoleukodystrophy (ALD) is characterized by adrenal insufficiency and neurologic involvement with onset at variable ages. Plasma very long chain fatty acids are elevated in ALD; even in asymptomatic patients. We demonstrated previously that liquid chromatography tandem mass spectrometry measuring C26:0 lysophosphatidylcholine reliably identifies affected males. We prospectively applied this method to 4689 newborn blood spot samples; no false positives were observed. We show that high throughput neonatal screening for ALD is methodologically feasible.
DOI: 10.1002/ana.101
发表时间: 2001-04-01
影响因子: 11.2
作者:
Bezman, L;Moser, AB;Moser, HW
通讯作者: Moser, HW
DOI: 10.1016/j.ymgme.2009.03.010
发表时间: 2009-07-01
影响因子: 3.8
作者:
Hubbard, Walter C.;Moser, Ann B.;Raymond, Gerald V.
通讯作者: Raymond, Gerald V.
DOI: 10.1007/s00431-011-1401-1
发表时间: 2011-08-01
影响因子: 3.6
作者:
Polgreen, Lynda E.;Chahla, Saydi;Petryk, Anna
通讯作者: Petryk, Anna
DOI: 10.1111/j.1750-3639.2010.00394.x
发表时间: 2010-07-01
期刊: BRAIN PATHOLOGY
影响因子: 6.4
作者:
Cartier, Nathalie;Aubourg, Patrick
通讯作者: Aubourg, Patrick
DOI: 10.1016/j.ymgme.2006.05.001
发表时间: 2006-09-01
影响因子: 3.8
作者:
Hubbard, Walter C.;Moser, Ann B.;Moser, Hugo
通讯作者: Moser, Hugo